Chemical Stimulation Of Growth Or Activity By Addition Of Chemical Compound Which Is Not An Essential Growth Factor; Stimulation Of Growth By Removal Of A Chemical Compound Patents (Class 435/244)
  • Publication number: 20010055787
    Abstract: A novel agar medium for the isolation, sub-cultivation, and indirect or direct drug-susceptibility testing of Mycobacterium tuberculosis is disclosed. Also disclosed are methods of isolating and growing Mycobacterium tuberculosis and methods of drug-resistance screening using the agar medium of the invention.
    Type: Application
    Filed: March 20, 2001
    Publication date: December 27, 2001
    Inventors: Leonid Heifets, Tracy Sanchez
  • Patent number: 6312955
    Abstract: The present invention features gram-positive bacteria resistant to 5-fluorodeoxyuridine (FUdR). Such bacteria will preferably be commensal, and will not be resistant to antibiotics. Bacteria according to the present invention may also be transformed with DNA encoding an antigenic protein. Such transformed bacteria may be used to formulate a vaccine, in order to stimulate an immune response to the antigenic protein in a patient. The present invention further provides a method for isolating gram-positive bacteria resistant to FUdR.
    Type: Grant
    Filed: April 29, 1999
    Date of Patent: November 6, 2001
    Assignee: Siga Pharmaceuticals
    Inventors: Dennis E. Hruby, Christine A. Franke
  • Patent number: 6309835
    Abstract: Methods are included for quantitating the efficacy of oral care products at dislodging cells from biofilm test surfaces or inhibit or delay the accumulation of cells on a test surface. More specifically, the inventive methods measure the effectiveness of compositions and appliances in a test environment that models biofilm surface orientations that are encountered on a tooth surface, i.e. interproximal and subgingival tooth surfaces. The use of test surfaces that are removably attachable to a tooth prosthesis allow a variety of different quantitative methods to be applied to determine the amount of cells removed or deposited in a biofilm.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: October 30, 2001
    Assignee: Koninkiijke Philips Electronics N.V.
    Inventors: Lokanathan M. Iyer, Robert E. Akridge, James C. McInnes
  • Publication number: 20010033835
    Abstract: The present invention provides a serum-free supplement which supports the growth of hematopoietic cells in culture. Also provided are a medium comprising a basal medium supplemented with the serum-free supplement of the present invention. The present invention also provides methods for culturing and for differentiating hematopoietic cells.
    Type: Application
    Filed: January 31, 1997
    Publication date: October 25, 2001
    Inventors: JOHN P. DALEY, BARBARA M. DADEY, WILLIAM C. BIDDLE, MICHELLE G. WYSOCKI
  • Patent number: 6306638
    Abstract: Bifidobacteria strains and mutants thereof having tolerance in the gastrointestinal environments and to a method for culturing the same. Strains of the invention include Bifidobacterium longum ATCC No.(s) 55815, 55816, 55817 and 55818. All of which have tolerances against bile salt, acid and oxygen and which have been obtained through mutagenesis and screening for tolerances against bile salt, acid and oxygen by using acid tolerant using acid-tolerant Bifidobacterium longum Y1 and Y2 strains (ATCC 55813 and 55814). These strains can be isolated from healthy infant feces as the parent strains. Further, an isolated Bifidobacterium mutant strain which grows aerobically, is ten times more tolerant to hydrochloric acid at a pH of 1.5 to 4.5 and is also tolerant to oxgall at 0.3% in a culture medium is disclosed. The strains show excellent growth under aerobic condition in the presence of skim milk without supplement of other growth promoting substances.
    Type: Grant
    Filed: December 30, 1997
    Date of Patent: October 23, 2001
    Assignee: Food Industry Research and Development Institute
    Inventors: Yuann-Shiuann Yang, Mei-Ching Chen, Chii-Cherng Liao
  • Patent number: 6294351
    Abstract: A method of biochemically transforming macromolecular compounds found in solid carbonaceous materials, such as coal is provided. The preparation of new microorganisms, metabolically weaned through challenge growth processes to biochemically transform solid carbonaceous materials at extreme temperatures, pressures, pH, salt and toxic metal concentrations is also disclosed.
    Type: Grant
    Filed: October 15, 1998
    Date of Patent: September 25, 2001
    Assignee: Brookhaven Science Associates, LLC
    Inventors: Mow S. Lin, Eugene T. Premuzic
  • Patent number: 6287873
    Abstract: A microbial consortium, ATCC 202177, is enriched to remove target sulfur compounds from gases in the presence of ammonia, cyanide, carbon monoxide, and other toxic gases and mixtures thereof. The ATCC 202177 consortium is cultured in an anaerobic or aerobic nutrient medium until enough cells of ATCC 202177 are recovered to remove the target sulfur species at a pressure ranging from 1 to 80 atmospheres.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: September 11, 2001
    Assignee: Arctech Inc.
    Inventors: Kailish C. Srivastava, Seema Garg, Daman S. Walia
  • Patent number: 6277575
    Abstract: The malignant or otherwise diseased state of a cell can be determined in tissues fixed by techniques such as the formalin and parafin methods. This determination is made by (1) studying the precise conformation (i.e. position and structure) of at least one gene within a chromosome of a targeted cell and (2) measuring the deviation of gene conformation in comparison to a non-diseased cell. Accordingly, methods for evaluating the malignancy index of cells, as well as monitoring the effectiveness of therapeutic treatment, are provided.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: August 21, 2001
    Inventor: Fabien Calvo
  • Patent number: 6268206
    Abstract: A composition containing cAMP, cGMP, forskolin, adenylate cyclase or guanylate cyclase and microorganisms is provided to facilitate bioremediation, detoxication and to enhance plant growth in media contaminated with petroleum hydrocarbons. Methods to make the composition and apply it to the contaminated media in order to facilitate bioremediation and detoxication of such contaminants are also provided.
    Type: Grant
    Filed: October 14, 1999
    Date of Patent: July 31, 2001
    Inventor: David Liptak
  • Patent number: 6267888
    Abstract: A method for removal of free-floating oil from an aqueous environment by bio-dispersion and bio-utilization comprising the steps of: (i) isolating species/strains of bacteria having an ability to utilize hydrocarbons as the only source of carbon; (ii) admixing the bacteria with a fatty substance and hydrocarbon oil to form an oleophilic suspension comprising a physiologically active bacterial culture of hydrocarbonoclastic bacteria, the fatty substance comprising an oleophilic nutrient as a source of nitrogen and phosphorus for the bacteria, and (iii) applying the oleophilic suspension of the bacteria to a free floating oil in an aqueous environment to disperse and remove free-floating oil therefrom.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: July 31, 2001
    Inventor: Ganti Satyanarayana
  • Patent number: 6265180
    Abstract: Sterile nanoemulsions are prepared containing oily droplets of a diameter of less than 100 nm in an aqueous phase. The oily droplets contain a lipophilic substance, and have on their surface an amphoteric emulsifier in an amount of preferably 0.65 to 0.75 parts by weight amphoteric emulsifier for one part by weight of oily component forming the droplets. The oily component of the droplets is preferably a triglyceride containing oleic acid and/or linoleic acid. The nanoemulsions are used for delivering into cells the lipophilic substance contained by the oily droplets. This delivery can be used to biotransform the lipophilic substance, promote cell differentiation, growth or biosynthesis of a desired substance, or to test for toxicity of the lipophilic substance.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: July 24, 2001
    Assignee: Mibelle AG Cosmetics
    Inventors: Fred Zuelli, Franz Suter
  • Publication number: 20010006808
    Abstract: A fermentation process post-sterile additive device and method of operation is detailed. The device is used to deliver additive as a heavy-drop mist. The mist covers the entire fermenting batch head surface of the vat broth. This improves mixing and reduces the amount of additive to appropriate introduction levels throughout log phase fermentation, preventing coating of cultivating cells and interference with cell respiration. A steady state growth rate is fostered.
    Type: Application
    Filed: July 15, 1999
    Publication date: July 5, 2001
    Inventor: DREW C. COLEMAN
  • Patent number: 6255100
    Abstract: It has been found that nonimmunosuppressive, cyclophilin-binding cyclosporins are useful in the treatment and prevention of AIDS and AIDS-related disorders. Such cyclosporins include novel Ciclosporin derivatives modified at the 4- and/or 5-positions.
    Type: Grant
    Filed: September 9, 1999
    Date of Patent: July 3, 2001
    Assignee: Novartis AG
    Inventors: Soo Young Ko, Hans Kobel, Brigitte Besemer-Rosenwirth, Dieter Seebach, RenéP. Traber, Roland Wenger, Pietro Bollinger
  • Patent number: 6251144
    Abstract: During the desizing and enzymatic stonewashing of denim fabric and/or garments, redeposition of blue color often occurs back onto the surfaces of the denim. The invention relates to a redepositing or backstain inhibiting composition and a method requiring the inclusion of an added protease prior to, during or subsequent to the stonewashing process which reduces the redeposition of the blue dye and hence improves the stonewashing process when using redepositing or backstaining cellulases to give an appearance closer to that when using stones alone or nonredepositing cellulases in the stonewashing process.
    Type: Grant
    Filed: February 10, 1995
    Date of Patent: June 26, 2001
    Assignee: Genencor International, Inc.
    Inventors: Kathleen A. Clarkson, Pushkaraj J. Lad, M. M. Mullins, Curran M. Simpson, Geoffrey L. Weiss, Lindsay Jacobs
  • Patent number: 6248572
    Abstract: The present invention provides a method for mass production of taxol which comprises adding sugar into a culture medium containing sugar in the course of semicontinuous culture of Taxus genus plant cell, and a universal method for mass production of taxol which comprises culturing Taxus genus plant cell in a culture medium containing sugar and AgNO3 as well. In accordance with the present invention, large amount of taxol can be produced with a high yield, simply by manipulating the culture condition of Taxus genus plant cell culture.
    Type: Grant
    Filed: December 22, 1998
    Date of Patent: June 19, 2001
    Assignee: Samyang, Genex, Corporation
    Inventors: Hyung-Kyoon Choi, Tom Lee Adams, Roy William Stahlhut, Sang-Ic Kim, Jeong-Hwan Yun, Bong-Kyu Song, Jin-Hyun Kim, Jun-Seog Song, Seung-Suh Hong, Hyun-Soo Lee, Ho-Joon Choi
  • Patent number: 6242210
    Abstract: An assay for compounds useful in the treatment of a bacterial induced coagulation disorder has the following steps: a) incubating a plasma sample with a strain of bacteria; b) adding a compound to be assayed to the plasma sample before, during or after step (a); c) conducting an activated partial thromboplastin time test; d) determining the clotting time.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: June 5, 2001
    Assignee: Actinova Limited
    Inventors: Lars Björck, Ulf Sjörbring, Abdelhakim Ben Nasr, Arne Olsén, Heiko Herwald, Werner Müller-Esterl, Eva Mattsson
  • Patent number: 6203792
    Abstract: This invention relates to the novel identification of myelin-associated glycoprotein (“MAG”) as a potent inhibitor of neural regeneration. More particularly, this invention relates to compositions and methods useful for reversing inhibition of neural regeneration in the central and peripheral nervous system. Assays to monitor the effects of MAG on neural regeneration and to identify agents which will block or promote the inhibitory effects of MAG on neural outgrowth are provided. Screening methods for identifying such agents are also provided. This invention also relates to compositions and methods using agents that can reverse the inhibitory effects of MAG on neural regeneration.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: March 20, 2001
    Assignee: Research Foundation of CUNY, Hunter College
    Inventor: Marie T. Filbin
  • Patent number: 6173527
    Abstract: An ozone containing gas is injected into a portion of top soil that was previously oversaturated with water, to stimulate the propagation and growth of living organisms. The injected ozone oxidizes at least one molecule (also called “parent molecule”) in the top soil to create at least one byproduct that is smaller than the parent molecule. The small size of such byproducts allows the byproducts to cause the growth of living organisms (such as plants including fungi and tomatoes). The byproducts can be used to grow a fungi (such as Trichoderma, spp.) that is (1) parasitic to detrimental fungi such as fusarium or is (2) a stimulant for chlorophyll-bearing plants, or is both. The byproducts can also be used to directly grow the chlorophyll-bearing plants. An ozone containing gas can be injected via a soil injector connected to an ozone supplier that is either stationary or is moved over a field, e.g. by a vehicle.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: January 16, 2001
    Assignee: Soilzone, Inc.
    Inventor: Alan E. Pryor
  • Patent number: 6168930
    Abstract: The present invention relates to a method for improving the growth and detection of bacteria, yeasts, fungi or cocci, by adding sterile-filtered yeast extract and/or p-iodonitrotetrazolium violet to the culture medium.
    Type: Grant
    Filed: January 8, 1997
    Date of Patent: January 2, 2001
    Assignee: Biotest AG
    Inventor: J{umlaut over (u)}rgen Horn
  • Patent number: 6156534
    Abstract: Disclosed is a process for the synthesis of .beta.-lactam antibacterials using soluble side chain esters in the presence of enzyme acylase. Also disclosed are novel esters useful as reactants in said process.
    Type: Grant
    Filed: October 22, 1998
    Date of Patent: December 5, 2000
    Assignee: Bristol-Myers Squibb Company
    Inventors: John J. Usher, Guna Romancik
  • Patent number: 6153422
    Abstract: An oxygen absorber is provided which is obtainable by mixing 10 to 60 parts by weight of a particulate thermoplastic resin having a softening point of 90 to 125.degree. C. and a particle diameter of 1 to 500 .mu.m with 100 parts by weight of an oxygen absorbing composition containing an ascorbic acid compound, water and an activated carbon. The oxygen absorber can inhibit overheat to prevent spontaneous ignition. Further, the activated carbon has a particle diameter of 0.1 to 2 mm and the ascorbic acid compound includes L-ascorbic acid, sodium L-ascorbate, calcium L-ascorbate and sodium D-iso-ascorbate.
    Type: Grant
    Filed: March 9, 1998
    Date of Patent: November 28, 2000
    Assignee: Mitsubishi Gas Chemical Company, Inc.
    Inventor: Takashi Kashiba
  • Patent number: 6150133
    Abstract: A process of culturing a microorganism in a culture medium in which process the addition of feed medium is controlled by using the production of a by-product as a measure of the culture conditions, characterized in that the by-product is an electrically charged metabolite produced by the microorganism, and in that the production of the metabolite is monitored by measuring the conductance of the culture medium. The metabolite may be acetate and the microorganism may be yeast which is genetically engineered to produce a desired polypeptide.
    Type: Grant
    Filed: September 11, 1998
    Date of Patent: November 21, 2000
    Assignee: Delta Biotechnology Limited
    Inventors: David John Mead, Hendrik Van Urk
  • Patent number: 6136554
    Abstract: The present invention is directed to methods and media for the growth, enrichment, isolation, and presumptive identification of enteric pathogens such as E. coli 0157:H7 and Salmonella. In particular, the organisms commonly associated with gastrointestinal infections of humans and other animals are distinguished based on their growth, colonial morphology and color. The present invention is also directed to methods and media for the growth, enrichment, isolation and presumptive identification of enteric pathogens such as E. coli 0157:H7 and Salmonella isolated from food, water, dairy, and environmental samples.
    Type: Grant
    Filed: March 17, 1997
    Date of Patent: October 24, 2000
    Assignee: Biolog, Inc.
    Inventor: Barry Bochner
  • Patent number: 6132993
    Abstract: Methods are provided for improving the microbial production of amphotericin B by the selective inhibition of amphotericin A by means of protein synthesis inhibitors.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: October 17, 2000
    Assignee: Rutgers University
    Inventors: Carl P. Schaffner, David J. Kientzler
  • Patent number: 6127167
    Abstract: Disclosed herein is a method of controlling the proliferation of an aerobe, in which in the continuous culture of the aerobe by supplying a substrate and oxygen to a culture tank of the aerobe to cause the aerobe to decompose the substrate, the proliferation of the aerobe is inhibited while retaining the substrate-decomposing activity inherent in the aerobe. An oxidation-reduction substance which is reduced by electrons donated by an electron transport system of the aerobe and oxidized by oxygen supplied to the culture tank is caused to coexist with the aerobe in the culture tank.
    Type: Grant
    Filed: June 28, 1996
    Date of Patent: October 3, 2000
    Assignee: Honda Giken Kogyo Kabushiki Kaisha
    Inventors: Shigeru Maruyama, Takuya Sato, Akio Yamamoto, Yuichiro Tanaka
  • Patent number: 6124112
    Abstract: The invention relates to a method of production for a fermentation product, in which ripe compost is subjected to treatment with worms, bacteria and fungi, after which the fermentation product is dug off, and, if necessary, ground and sifted. After digging off the product, it can be pre-dehydrated at a temperature below 50 .degree. C., if one so wishes, then --if necessary--it can be ground and sifted, and be subjected to desiccation, during which the temperature of the fermentation product does not rise above 30.degree. C. during the desiccation process. Ripe compost, consisting of vegetable, fruit and garden waste, is especially suitable as basic material. If one so wishes, the fermentation product can be pelleted before desiccation. The pellets can, for example, be used as floor cover in animal pens or as cat's box litter. The non-dried product is especially suitable as a supplement for garden and pot-plant soil.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: September 26, 2000
    Inventor: Jan Molenaar
  • Patent number: 6087131
    Abstract: An acid-stable .beta.-glucosidase that may be prepared from filamentous fungi and has very low glucose inhibition sensitivity is disclosed. Said .beta.-glucosidase is particularly useful for preparing fruit juices and in enzymatic cellulose hydrolysis methods.
    Type: Grant
    Filed: January 6, 1998
    Date of Patent: July 11, 2000
    Assignee: Institut National de la Recherche Agronomique - I.N.R.A.
    Inventors: Yusuf Ziya Gunata, Marie-Jose Vallier, Raymond Baumes, Claude Bayonove
  • Patent number: 6080562
    Abstract: Microorganisms are modified to permit production of HV/HB copolymers from substrates such as glucose by inducing amiono acid overproduction in those capable of synthesising and polymerising hydroxybutyrate or adding to an amino acid overproducer the genetic material necessary for it to synthesise and polymerise hydroxybutrate.
    Type: Grant
    Filed: November 25, 1992
    Date of Patent: June 27, 2000
    Assignee: Monsanto Company
    Inventors: David Byrom, Alexander Steinbuchel
  • Patent number: 6071910
    Abstract: A therapeutic method comprising counteracting or preventing pathologies mediated by IL-5, including those characterized by eosinophil infiltration, degranulation and inflammation, by administering to a mammal in need of such therapy, one or more compounds that bind to the eosinophil sulfonylurea receptor, optionally in combination with one or more topical anesthetics and/or glucocorticoids.
    Type: Grant
    Filed: December 5, 1997
    Date of Patent: June 6, 2000
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Gerald J. Gleich, Jennifer L. Bankers-Fulbright
  • Patent number: 6033907
    Abstract: A method to increase the efficiency of transduction of hematopoietic and other cells by retroviruses includes infecting the cells in the presence of fibronectin or fibronectin fragments. The fibronectin and fibronectin fragments significantly enhance retroviral-mediated gene transfer into the cells, particularly hematopoietic cells including committed progenitors and primitive hematopoietic stem cells. The invention also provides improved methods for somatic gene therapy capitalizing on enhanced gene transfer, hematopoietic cellular populations, and novel constructs for enhancing retroviral-mediated DNA transfer into cells and their use.
    Type: Grant
    Filed: September 29, 1995
    Date of Patent: March 7, 2000
    Assignee: Indiana University Foundation
    Inventor: David A. Williams
  • Patent number: 6004551
    Abstract: This invention relates to lactobacillus, skim milk, lactobacillus growth factor (LGF) and lactobacillus compositions and methods of employing said composition for preventing urogenital infections. More particularly, this invention relates to the ability of strains of hydrophobic or hydrophilic lactobacillus to adhere to biomaterials, intestinal, vaginal and uroepithelial cells, to resist the action of certain anti-microbial agents and to dominate the urogenital flora.
    Type: Grant
    Filed: November 26, 1996
    Date of Patent: December 21, 1999
    Assignee: Urex Biotech, Inc.
    Inventors: Gregor Reid, Andrew W. Bruce
  • Patent number: 5998182
    Abstract: Disclosed are a deterioration inhibitor for an emulsion-type processing oil comprising, as an active ingredient, a culture of a bacterial species selected from the group consisting of Aerococcus viridans BC-A-4 (Acceptance No. FERM BP-5042), Bacillus brevis BC-A-69 (Acceptance No. FERM BP-5041) and Bacillus brevis BC-A-3124 (Acceptance No. FERM BP-5043) and a method for inhibiting deterioration of an emulsion-type processing oil comprising adding such deterioration inhibitor to the emulsion-type processing oil and then allowing the bacteria contained in the deterioration inhibitor to proliferate. Since the propagation of the putrefying bacteria in the emulsion-type processing oils can be suppressed by the proliferation of the bacteria contained in the deterioration inhibitor, the working life of the emulsion-type processing oil can be prolonged.
    Type: Grant
    Filed: May 9, 1997
    Date of Patent: December 7, 1999
    Assignee: Mazda Motor Corporation
    Inventors: Hironari Nagahara, Hisao Yamasaki, Takashi Miyama, Nobuhiro Ito
  • Patent number: 5989891
    Abstract: The present invention relates to a process for the production of 2-keto-L-gulonic acid by fermentative conversion of L-sorbose and/or D-sorbitol. The present invention further relates to novel bacterial strains useful in this process.
    Type: Grant
    Filed: July 11, 1997
    Date of Patent: November 23, 1999
    Assignee: Archer-Daniels-Midland Company
    Inventors: Hungming J. Liaw, John Eddington, Yueqin Yang
  • Patent number: 5968789
    Abstract: This invention relates to a method of producing a taxane-type diterpene(s) wherein tissues or cells of a plant which produces taxane-type diterpene(s) is cultured in the presence of at least one selected from the group consisting of jasmonic acids, compounds containing a heavy metal, complex ions containing a heavy metal, heavy metal ions, amines and antiethylene agents, a method of producing a taxane-type diterpene wherein the tissues or the cells of the plant are cultured by controlling the oxygen concentration in a gas phase in a culture vessel to less than the oxygen concentration in the atmosphere from the initial stage of the culture, or by controlling the dissolved oxygen concentration in a fluid medium which is in contact with the tissue or the cell to less than the saturated dissolved oxygen concentration at that temperature from the initial stage of the culture, a method of producing a taxane-type diterpene wherein the tissue or the cell of the plant is cultured in a culture vessel, while oxygenic g
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: October 19, 1999
    Assignee: Mitsui Chemicals, Ltd.
    Inventors: Yukihito Yukimune, Yasuhiro Hara, Yosuke Higashi, Naoto Ohnishi, Homare Tabata, Chuzo Suga, Kouichi Matsubara
  • Patent number: 5939309
    Abstract: A Bifidobacterium bifidum proliferation promoting composition comprising a xylooligosaccharide which contains xylobiose as its principal component is disclosed. The xylooligosaccharide is obtained by enzymatically or physicochemically treating either xylan or hemicellulose derived from a natural source. Bifidobacterium bifidum which is useful for man is encouraged to proliferate in the intestines by the xylooligosaccharide which is not readily assimilated by Escherichia coli but is readily utilized by Bifidobacterium bifidum. The xylooligosaccharide is advantageously stable when exposed to acids or heat.
    Type: Grant
    Filed: April 2, 1997
    Date of Patent: August 17, 1999
    Assignee: Suntory Limited
    Inventors: Yoshihide Suwa, Kunimasa Koga, Shigeaki Fujikawa, Masako Okazaki, Toshio Irie, Toshiyuki Nakada
  • Patent number: 5925550
    Abstract: The present invention relates to a method for selectively enhancing the production of factors A.sub.2 and/or A.sub.3 of antibiotic A/16686 either to isolate these single components or to enrich the complex in one or both the above components, which comprises adding an appropriate precursor of the desired antibiotic factor to an A/16686 producing culture during fermentation.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: July 20, 1999
    Assignee: Biosearch Italia S.p.A.
    Inventors: Giancarlo Lancini, Angelo Borghi, Piero Antonini
  • Patent number: 5888788
    Abstract: The addition of about 0.3 to about 3 ppm of at least one polyether ionoph antibiotic to a fermentation broth inhibits production of organic acids that hinder the growth and fermentation of yeast. The present invention is useful in a variety of feedstocks, including sugar beet juice, sugar cane juice, diluted sugar beet molasses, diluted sugar cane molasses, hydrolyzed grain (e.g., corn or wheat), hydrolyzed starchy tubers (e.g., potatoes or Jerusalem artichokes), wine, wine by-products, cider, and cider by-products.
    Type: Grant
    Filed: November 16, 1995
    Date of Patent: March 30, 1999
    Assignee: Union Nationale des Groupements de Distillateurs d'Alcool (UNGDA)
    Inventor: Michel De Miniac
  • Patent number: 5877210
    Abstract: A method of inhibiting the proliferation of B cells by using inhibitors of phosphotyrosine phosphatase can be used to regulate the immune response and to treat diseases such as leukemias or lymphomas marked by malignant proliferation of B cells or T cells. Antitumor activity is seen in vivo against tumors and against tumor cell lines. The use of such inhibitors can be combined with radiation, which produces a synergistic effect. Several types of inhibitors can be used, including: (1) compounds comprising a metal coordinate-covalently bound to an organic moiety that can form a five- or six-membered ring, in which the metal is preferably vanadium (IV); (2) compounds in which vanadium (IV) is coordinate-covalently bound to an organic moiety such as a hydroxamate, .alpha.-hydroxypyridinone, .alpha.-hydroxypyrone, .alpha.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 2, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventor: Gary L. Schieven
  • Patent number: 5871979
    Abstract: The present invention relates to a method for mass production of taxol by semi-continuous culture of Taxus genus plant with a high yield. According to the present invention, taxol can be prepared with a high yield, by employing semi-continuous culture of Taxus genus plant cell, which comprises: (i) inoculating Taxus genus plant cell on a medium containing 1 to 10% (w/v) sugar, and incubating it; and, (ii) transferring 1/10 to 1/2 volume of the culture obtained in the step (i) to a fresh medium and repeating the step (i), adding 1 to 10% (w/v) sugar to the remnant culture and incubating to the time of maximum production of taxol.
    Type: Grant
    Filed: May 28, 1996
    Date of Patent: February 16, 1999
    Assignee: Samyang Genex Co., Ltd.
    Inventors: Hyung-Kyoon Choi, Tom Lee Adams, Roy William Stahlhut, Sang-Ic Kim, Jeong-Hwan Yun, Bong-Kyu Song, Jin-Hyun Kim, Jun-Seog Song, Seung-Suh Hong, Hyun-Soo Lee
  • Patent number: 5871952
    Abstract: A process for selection of oxygen-tolerant, H.sub.2 -producing algal mutant cells comprising:(a) growing algal cells photoautotrophically under fluorescent light to mid log phase;(b) inducing algal cells grown photoautrophically under fluorescent light to mid log phase in step (a) anaerobically by (1) resuspending the cells in a buffer solution and making said suspension anaerobic with an inert gas; (2) incubating the suspension in the absence of light at ambient temperature;(c) treating the cells from step (b) with metronidazole, sodium azide, and added oxygen to controlled concentrations in the presence of white light.(d) washing off metronidazole and sodium azide to obtain final cell suspension;(e) plating said final cell suspension on a minimal medium and incubating in light at a temperature sufficient to enable colonies to appear;(f) counting the number of colonies to determine the percent of mutant survivors; and(g) testing survivors to identify oxygen-tolerant H.sub.2 -producing mutants.
    Type: Grant
    Filed: April 14, 1997
    Date of Patent: February 16, 1999
    Assignee: Midwest Research Institute
    Inventors: Maria L. Ghirardi, Michael Seibert
  • Patent number: 5863789
    Abstract: A carrier for holding a microorganism in soil releases, from a constituting material thereof, an inducer for production of an enzyme of the microorganism for soil remediation. The carrier for holding a microorganism may comprise a combination of a microorganism holding carrier composed of a hydrophilic polymer for holding the microorganism with an inducer-holder composed of another polymer for holding inducer manifesting a biological action to the microorganism adjacent to each other. A method for remediation of soil comprises application of the microorganism-holding carrier into the soil. A soil-remedying agent comprises the microorganism-holding carrier and a microorganism held thereon which exhibits enzyme activity for decomposition of a polluting substance in the soil under action an inducer released by the carrier.
    Type: Grant
    Filed: July 24, 1997
    Date of Patent: January 26, 1999
    Assignee: Canon Kabushiki Kaisha
    Inventors: Toshiyuki Komatsu, Masanori Sakuranaga, Tsuyoshi Nomoto, Shinya Kozaki, Takeshi Imamura
  • Patent number: 5854059
    Abstract: An organic compound is biodegraded using JM1 (FERM BP-5352) by contacting the JM1 with an organic compound and culturing the JM1 in a medium including source of conjugated carbon which is citric acid, maleic acid or a salt thereof.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: December 29, 1998
    Assignee: Canon Kabushiki Kaisha
    Inventors: Shinya Kozaki, Tetsuya Yano, Chieko Mihara, Takeshi Imamura
  • Patent number: 5854012
    Abstract: Compositions, methods and apparatus (kits) for treating petroleum and petro-chemical based contaminants within expended filtration components, wherein the filtration components are exposed to water and a small concentrated volume of dormant bio-oxidizing medium comprising freeze-dried microorganisms on a freeze-dried substrate.
    Type: Grant
    Filed: December 17, 1997
    Date of Patent: December 29, 1998
    Assignee: Dana Corporation
    Inventors: William M. Lasky, James H. Cornwell
  • Patent number: 5851807
    Abstract: A process for providing vicinal dimethyl long chain between alkyl groups of organic compounds is described. The process uses intact or disrupted cells of various species of bacteria, particularly Thermoanaerobacter sp., Sarcina sp. and Butyrivibrio sp. The process can be conducted in an aqueous reaction mixture at room temperatures.
    Type: Grant
    Filed: January 17, 1997
    Date of Patent: December 22, 1998
    Assignee: Board of Trustees operating Michigan State University
    Inventors: Rawle I. Hollingsworth, Seunho Jung, Carol A. Mindock
  • Patent number: 5849550
    Abstract: A method for producing lysocellin in bead form comprises:(a) cultivating a lysocellin-producing microorganism in an aqueous nutrient-containing fermentation broth under lysocellin-producing conditions;(b) adding a base or inorganic phosphate to the fermentation broth within about the first 24 hours of the beginning of the fermentation in an amount sufficient to ensure that the lysocellin is produced in the form of a cation salt of lysocellin;(c) providing a lipid to the fermentation broth such that the lipid is present in the broth in a sufficient amount to form discrete beads with the lysocellin in the fermentation broth; and(d) separating the beads from the broth.
    Type: Grant
    Filed: June 30, 1995
    Date of Patent: December 15, 1998
    Assignee: Mallinckrodt Veterinary, Inc.
    Inventors: Donald R. Hahn, James R. McMullen, Vikram P. Mehrotra
  • Patent number: 5849289
    Abstract: The antibiotic reuterin is obtained by cultivating strains of Lactobacillus reuteri under controlled conditions. Reuterin has inhibitory activity against Gram positive and Gram negative bacteria, against the yeast, Saccharomyces cerevisiae, and against the protozoan, Trypanosoma cruzi. Reuterin-producing strains are identified by growth inhibition of susceptible microorganisms in the presence of glycerol or glyceraldehyde. Lactobacillus reuteri strains may be used for reducing the number of non-Lactobacillus reuteri bacteria in food items and in the gastrointestinal tracts of animals.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 15, 1998
    Assignee: Biogaia Biologics AB
    Inventors: Walter J. Dobrogosz, Sven E. Lindgren
  • Patent number: 5846743
    Abstract: Methods and compositions for facilitating the transport of a membrane-impermeable extracellular agent having an intracellular activity across the membrane of a cell are provided. The methods involve covalently coupling an amino terminal blocking group to a transport-mediating peptide to form a carrier molecule. The carrier molecule is covalently coupled to the extracellular agent to form a membrane-permeable prodrug. The transport-mediating peptides are highly basic and bind to polyphosphoinositides.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: December 8, 1998
    Assignee: Brigham and Women's Hospital, Inc.
    Inventors: Paul A. Janmey, C. Casey Cunningham, John H. Hartwig, Thomas P. Stossel, Roland Vegner
  • Patent number: 5846793
    Abstract: A process for preparing optically active (R)-3-chloro-1,2-propanediol, which comprises subjecting (R,S)-3-chloro-1,2-propanediol to the reaction of a microorganism belonging to genus Serratia in a reaction mixture, and then collecting the residual (R)-3-chloro-1,2-propanediol. According to the process of the present invention, (R)-3-chloro-1,2-propanediol can be efficiently prepared starting from low cost (R,S)-3-chloro-1,2-propanediol.
    Type: Grant
    Filed: December 27, 1990
    Date of Patent: December 8, 1998
    Assignee: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha
    Inventors: Hideyuki Takahashi, Satoru Tsuda, Yoshio Nakamura, Masahiro Ogura, Tadayoshi Shiraishi, Yoshio Shimada, Kiyoshi Watanabe
  • Patent number: 5843679
    Abstract: The present invention is directed to a method for selectively enhancing the production of factors A, and/or B.sub.0 of antibiotic A 40926 either to isolate these single components in better yields or to enrich the complex in one or both the above components, which comprises adding an appropriate precursor of the desired antibiotic factor to an A 40926 producing culture during fermentation.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: December 1, 1998
    Assignee: Biosearch Italia S.p.A.
    Inventors: Enrico Selva, Luciano Gastaldo, Maurizio Denaro, Giovanni Cassani, Francesco Parenti
  • Patent number: 5840548
    Abstract: The present invention relates to a process for producing lipids, which comprises culturing bacteria capable of assimilating aliphatic hydrocarbons and accumulating lipids in medium containing aliphatic hydrocarbons until lipids are accumulated in the bacteria and then recovering the lipids therefrom, as well as to process for producing cosmetics which comprises using the lipids produced by said method.
    Type: Grant
    Filed: September 12, 1995
    Date of Patent: November 24, 1998
    Assignee: Kashima Oil Co., Ltd.
    Inventors: Kimihiko Ogihara, Masamichi Sato, Kazunori Ishigami, Kouki Sakashita, Yoshihiro Takayama